News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
752,286 Results
Type
Article (44530)
Company Profile (317)
Press Release (707418)
Multimedia
Podcasts (128)
Webinars (22)
Section
Business (211733)
Career Advice (2124)
Deals (36889)
Drug Delivery (143)
Drug Development (83779)
Employer Resources (178)
FDA (16991)
Job Trends (15591)
News (358843)
Policy (34290)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2654)
Accelerated approval (45)
Adcomms (28)
Allergies (176)
Alliances (51799)
ALS (207)
Alzheimer's disease (1800)
Antibody-drug conjugate (ADC) (443)
Approvals (17354)
Artificial intelligence (664)
Autoimmune disease (260)
Automation (53)
Bankruptcy (373)
Best Places to Work (11822)
BIOSECURE Act (21)
Biosimilars (223)
Biotechnology (191)
Bladder cancer (184)
Brain cancer (74)
Breast cancer (734)
Cancer (5751)
Cardiovascular disease (471)
Career advice (1808)
Career pathing (42)
CAR-T (323)
CDC (57)
Celiac Disease (3)
Cell therapy (866)
Cervical cancer (46)
Clinical research (72367)
Collaboration (2079)
Company closure (5)
Compensation (1341)
Complete response letters (85)
COVID-19 (2812)
CRISPR (110)
C-suite (1100)
Cystic fibrosis (155)
Data (7590)
Decentralized trials (3)
Denatured (38)
Depression (161)
Dermatology (76)
Diabetes (583)
Diagnostics (7026)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (320)
Drug pricing (221)
Drug shortages (34)
Duchenne muscular dystrophy (277)
Earnings (93327)
Editorial (67)
Employer branding (21)
Employer resources (157)
Events (122600)
Executive appointments (1095)
FDA (20660)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1704)
Gene editing (232)
Generative AI (57)
Gene therapy (710)
GLP-1 (1092)
Government (4881)
Grass and pollen (7)
Guidances (404)
Healthcare (19261)
HIV (77)
Huntington's disease (56)
IgA nephropathy (95)
Immunology and inflammation (295)
Immuno-oncology (89)
Indications (177)
Infectious disease (3147)
Inflammatory bowel disease (213)
Inflation Reduction Act (14)
Influenza (135)
Intellectual property (289)
Interviews (330)
IPO (16985)
IRA (57)
Job creations (4079)
Job search strategy (1508)
JPM (65)
Kidney cancer (18)
Labor market (96)
Layoffs (587)
Leadership (39)
Legal (8454)
Liver cancer (100)
Longevity (33)
Lung cancer (760)
Lymphoma (424)
Machine learning (60)
Management (60)
Manufacturing (1025)
MASH (185)
Medical device (14119)
Medtech (14217)
Mergers & acquisitions (21124)
Metabolic disorders (1505)
mRNA (207)
Multiple sclerosis (184)
NASH (18)
Neurodegenerative disease (408)
Neuropsychiatric disorders (107)
Neuroscience (3302)
Neurotech (1)
NextGen: Class of 2026 (6676)
Non-profit (4593)
Now hiring (76)
Obesity (712)
Opinion (310)
Ovarian cancer (210)
Pain (264)
Pancreatic cancer (292)
Parkinson's disease (354)
Partnered (34)
Patents (590)
Patient recruitment (649)
Peanut (64)
People (61707)
Pharmaceutical (86)
Pharmacy benefit managers (34)
Phase 1 (22475)
Phase 2 (31840)
Phase 3 (23817)
Pipeline (8004)
Policy (327)
Postmarket research (2668)
Preclinical (9600)
Press Release (70)
Prostate cancer (292)
Psychedelics (55)
Radiopharmaceuticals (325)
Rare diseases (1070)
Real estate (6336)
Recruiting (73)
Regulatory (26269)
Reports (57)
Research institute (2475)
Resumes & cover letters (363)
Rett syndrome (36)
RNA editing (22)
RSV (88)
Schizophrenia (185)
Series A (286)
Series B (211)
Service/supplier (11)
Sickle cell disease (112)
Special edition (25)
Spinal muscular atrophy (169)
Sponsored (48)
Startups (3792)
State (2)
Stomach cancer (19)
Supply chain (128)
Tariffs (99)
The Weekly (88)
Vaccines (1113)
Venture capital (105)
Weight loss (469)
Women's health (121)
Worklife (20)
Date
Last 7 days (769)
Last 30 days (2736)
Last 365 days (30568)
2026 (10790)
2025 (30723)
2024 (35842)
2023 (40711)
2022 (51925)
2021 (56475)
2020 (54978)
2019 (47660)
2018 (35983)
2017 (33316)
2016 (32848)
2015 (38804)
2014 (32683)
2013 (27824)
2012 (29894)
2011 (30637)
2010 (28628)
Location
Africa (814)
Alabama (91)
Alaska (7)
Arizona (349)
Arkansas (16)
Asia (42817)
Australia (6958)
California (12899)
Canada (3694)
China (1342)
Colorado (551)
Connecticut (557)
Delaware (394)
Europe (92729)
Florida (1933)
Georgia (419)
Hawaii (3)
Idaho (63)
Illinois (1047)
India (91)
Indiana (595)
Iowa (23)
Japan (528)
Kansas (131)
Kentucky (50)
Louisiana (41)
Maine (75)
Maryland (1554)
Massachusetts (9228)
Michigan (358)
Minnesota (705)
Mississippi (6)
Missouri (143)
Montana (34)
Nebraska (29)
Nevada (139)
New Hampshire (84)
New Jersey (3418)
New Mexico (30)
New York (3393)
North Carolina (1655)
North Dakota (8)
Northern California (6423)
Ohio (383)
Oklahoma (24)
Oregon (46)
Pennsylvania (2602)
Puerto Rico (28)
Rhode Island (50)
South America (1181)
South Carolina (86)
South Dakota (2)
Southern California (5080)
Tennessee (208)
Texas (2043)
United States (45728)
Utah (385)
Vermont (1)
Virginia (324)
Washington D.C. (80)
Washington State (1039)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
752,286 Results for "zydus pharmaceuticals usa inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market
November 27, 2025
·
3 min read
Press Releases
Takara Bio USA, Inc. Validates New Class of Spatial Technology with Benchmark Study for Cancer Research
April 20, 2026
·
3 min read
Press Releases
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
January 16, 2026
·
3 min read
Press Releases
Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies
April 17, 2026
·
5 min read
Press Releases
Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones
April 30, 2026
·
21 min read
Press Releases
Codexis to share RNA manufacturing advances at TIDES USA
April 29, 2026
·
2 min read
Press Releases
Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO®, an Interchangeable Biosimilar to Lucentis®
December 24, 2025
·
3 min read
Press Releases
Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026
February 26, 2026
·
3 min read
Press Releases
Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs
March 10, 2026
·
6 min read
Press Releases
Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda® (Pembrolizumab), in the U.S. and Canada
December 10, 2025
·
7 min read
1 of 75,229
Next
